NCT02227173View on ClinicalTrials.gov

A Phase 1 Drug-drug Interaction Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Drug-drug Interaction Study
Interventions
DRUG

BMS-986020

DRUG

Montelukast

DRUG

Flurbiprofen

DRUG

Digoxin

Trial Locations (1)

78209

Healthcare Discoveries, LLC d/b/a ICON Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY